A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

Shulman DS, Vo KT, Balis FM, Lindsay H, DeNardo BD, Place AE, Chi SN, Kamihara J, O'Neill AF, Church AJ, Crompton BD, Klega K, Tanhaemami M, Armant M, Pikman Y, Stegmaier K, Ezrre S, Czaplinski J, Walensky LD, Annis DA, Bhushan K, Kao PC, London WB, DuBois SG

Open source

DOI: 10.1158/1078-0432.ccr-26-0625
Published: 2026 Aug 14
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0625,
  title = {A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.},
  author = {Shulman DS and Vo KT and Balis FM and Lindsay H and DeNardo BD and Place AE and Chi SN and Kamihara J and O'Neill AF and Church AJ and Crompton BD and Klega K and Tanhaemami M and Armant M and Pikman Y and Stegmaier K and Ezrre S and Czaplinski J and Walensky LD and Annis DA and Bhushan K and Kao PC and London WB and DuBois SG},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0625},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0625}
}

RIS

TY  - JOUR
TI  - A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.
AU  - Shulman DS
AU  - Vo KT
AU  - Balis FM
AU  - Lindsay H
AU  - DeNardo BD
AU  - Place AE
AU  - Chi SN
AU  - Kamihara J
AU  - O'Neill AF
AU  - Church AJ
AU  - Crompton BD
AU  - Klega K
AU  - Tanhaemami M
AU  - Armant M
AU  - Pikman Y
AU  - Stegmaier K
AU  - Ezrre S
AU  - Czaplinski J
AU  - Walensky LD
AU  - Annis DA
AU  - Bhushan K
AU  - Kao PC
AU  - London WB
AU  - DuBois SG
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0625
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0625
ER  -

APA

DS, S., KT, V., FM, B., H, L., BD, D., AE, P., SN, C., J, K., AF, O., AJ, C., BD, C., K, K., M, T., M, A., Y, P., K, S., S, E., J, C., LD, W., DA, A., K, B., PC, K., WB, L., & SG, D. (2026). A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0625

Source records

pubmed · retrieved 2026-09-26T05:37:07.629Z